CAS number：198821-22-6 molecular formula：C23H24N4O6
Merimepodib (VX-497) 是非竞争型，有口服活性的肌苷一磷酸脱氢酶 (IMPDH) 抑制剂，具有广谱抗病毒活性。 Information Merimepodib Merimepodib (Merimempodib, MMPD, VI-21,497, VX-497) is a potent, specific, and reversible inosine monophosphate dehydrogenase(IMPDH) inhibitor with antiviral activity against hepatitis C virus (HCV) and a variety of DNA and RNA viruses in vitro.Merimepodib is an immunosuppressive agent. Targets IMPDH
| Chinese alias | (S)-四氢呋喃-3-基 3-(3-(3-甲氧基-4-(恶唑-5-基)苯基)脲基)苄基氨基甲酸酯 | 美罗哌卡因 | ||
| English alias | PHENETHYLAMINE, beta-METHYL- | A919457 | Merimepodib [USAN:INN] | Merimebodib | 2-Naphthaleneacetic acid, 99% | carbamic acid, [[3-[[[[3-methoxy-4-(5-oxazolyl)phenyl]amino]carbonyl]amino]phenyl]methyl]-, (3S)-tetrahydro-3-furanyl ester | DTXSID70173639 | | ||
| CAS number | 198821-22-6 | molecular formula | C23H24N4O6 |
| molecular weight | 452.46 g/mol | Exact mass | - |
| PSA | 124.000 Ų | logp | 1.762 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
